# GCKR

## Overview
The GCKR gene encodes the glucokinase regulatory protein (GKRP), a pivotal component in glucose metabolism, primarily within the liver. GKRP functions as a regulatory protein, modulating the activity of glucokinase (GK) by acting as a competitive inhibitor. This regulation is crucial for maintaining glucose homeostasis, as GKRP sequesters GK in the nucleus during fasting, preventing its activity, and releases it in the cytoplasm postprandially to facilitate glycolysis and glycogen synthesis. The interaction between GKRP and GK is influenced by metabolic conditions, particularly the presence of fructose phosphates, which modulate the complex's stability. Variants in the GCKR gene have been associated with various metabolic disorders, including non-alcoholic fatty liver disease and familial combined hyperlipidemia, while also offering some protection against type 2 diabetes mellitus. The structural and functional dynamics of GKRP underscore its significant role in glucose and lipid metabolism (Zhang2023Glucokinase; Brouwers2015Modulation).

## Structure
The glucokinase regulatory protein (GCKR) is a key regulator of glucokinase activity, primarily in the liver. The primary structure of GCKR consists of a sequence of amino acids encoded by the GCKR gene. Its secondary structure includes alpha helices and beta sheets, which contribute to its overall stability and function (Baltrusch2001Characterization). The tertiary structure of GCKR forms a three-dimensional shape that is crucial for its interaction with glucokinase (GCK) and other molecules. This structure allows GCKR to bind to the super-open conformation of GCK, acting as a competitive inhibitor of glucose association with the enzyme (Sternisha2019Molecular).

GCKR contains specific domains, such as the sugar isomerase domains, which are involved in binding sugar phosphates like fructose 6-phosphate and fructose 1-phosphate. These domains play a significant role in modulating the stability of the GCK-GKRP complex (Beck2013Structural). Post-translational modifications, such as acetylation, can enhance GCKR's inhibitory potential and influence its cellular localization (Sternisha2019Molecular). The quaternary structure of GCKR involves forming a heterodimeric assembly with GCK, with a 1:1 stoichiometry, which is essential for its regulatory function (Beck2013Structural).

## Function
The GCKR gene encodes the glucokinase regulatory protein (GKRP), which plays a crucial role in regulating glucokinase (GK) activity in the liver. GKRP acts as an endogenous competitive inhibitor of GK, modulating its activity by binding to it and influencing its localization within the cell. In the fasting state, GKRP sequesters GK in the nucleus, preventing its activity and serving as a reserve for postprandial glucose elevation. Upon eating, GK dissociates from GKRP, becoming active in the cytoplasm to stimulate glycolysis and glycogen synthesis (Zhang2023Glucokinase).

The interaction between GK and GKRP is influenced by metabolic conditions, with fructose-1-phosphate disrupting the complex and promoting GK translocation to the cytoplasm, enhancing glucose uptake and glycogen storage. This regulation is essential for maintaining glucose homeostasis, as it ensures that GK is only active when blood glucose levels are elevated (Irwin2014Evolution; Massa2011Liver).

GKRP also stabilizes GK, protecting it from degradation, and its absence or mutation can lead to decreased GK expression and impaired glucose homeostasis. The GK/GKRP ratio is important for efficient glucose uptake and liver protection from metabolic excess (Farrelly1999Mice; Zhang2023Glucokinase).

## Clinical Significance
Mutations and variants in the GCKR gene, which encodes the glucokinase regulatory protein (GKRP), have been linked to several metabolic disorders. Common variants such as rs1260326 and rs780094 are associated with an increased risk of non-alcoholic fatty liver disease (NAFLD), familial combined hyperlipidemia (FCHL), and gout, while also providing some protection against type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) (Simons2018Association; Brouwers2015Modulation). The rs1260326 variant, in particular, is linked to increased triglyceride levels and decreased fasting plasma glucose, which may contribute to its protective effect against T2DM (OrhoMelander2008Common; Rees2011Cellular).

The GCKR gene's minor alleles can influence glucose and lipid metabolism, leading to conditions associated with the metabolic syndrome, such as high triglycerides and low HDL cholesterol (Brouwers2015Modulation). These genetic variations can also affect the binding of GKRP to glucokinase, altering glucose metabolism and potentially increasing hepatic fat accumulation (Brouwers2015Modulation). The pleiotropic effects of GCKR variants underscore their significant role in cardiometabolic disorders (Yeh2022Pleiotropic).

## Interactions
The glucokinase regulator (GCKR) protein is involved in several interactions with other proteins, playing a crucial role in glucose metabolism. GCKR interacts with glucokinase (GCK) to regulate its activity, influencing glucose homeostasis. This interaction is modulated by glucose and fructose phosphates, with fructose 1-phosphate disrupting and fructose 6-phosphate enhancing the GCK-GKRP interaction (Rees2014A; Zelent2014Analysis). 

GCKR also interacts with adaptor proteins Crk-I, Crk-II, and CrkL. These interactions are facilitated by specific regions within GCKR, particularly amino acids 386-398 and 599-696, which are important for binding with CrkL. The overexpression of Crk proteins enhances GCKR kinase activity, a process that is dependent on Ras (Shi2000Adaptor). 

In the context of cellular signaling, GCKR is involved in the formation of a trimolecular complex with Bcr-Abl and CrkL, facilitated by CrkL's SH3 domain binding to Bcr-Abl. This interaction suggests a role for GCKR in modulating the activity of other signaling molecules, potentially linking it to the stress-activated protein kinase (SAPK) pathway (Shi2000Adaptor).


## References


[1. (Zhang2023Glucokinase) Ziqi Zhang, Guang Ji, and Meng Li. Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in nafld. Frontiers in Endocrinology, August 2023. URL: http://dx.doi.org/10.3389/fendo.2023.1247611, doi:10.3389/fendo.2023.1247611. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2023.1247611)

[2. (Sternisha2019Molecular) Shawn M. Sternisha and Brian G. Miller. Molecular and cellular regulation of human glucokinase. Archives of Biochemistry and Biophysics, 663:199–213, March 2019. URL: http://dx.doi.org/10.1016/j.abb.2019.01.011, doi:10.1016/j.abb.2019.01.011. This article has 117 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2019.01.011)

[3. (Baltrusch2001Characterization) Simone Baltrusch, Sigurd Lenzen, David A. Okar, Alex J. Lange, and Markus Tiedge. Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Journal of Biological Chemistry, 276(47):43915–43923, November 2001. URL: http://dx.doi.org/10.1074/jbc.m105470200, doi:10.1074/jbc.m105470200. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m105470200)

[4. (Rees2014A) Matthew G. Rees, Mindy I. Davis, Min Shen, Steve Titus, Anne Raimondo, Amy Barrett, Anna L. Gloyn, Francis S. Collins, and Anton Simeonov. A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease. PLoS ONE, 9(2):e89335, February 2014. URL: http://dx.doi.org/10.1371/journal.pone.0089335, doi:10.1371/journal.pone.0089335. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0089335)

[5. (Farrelly1999Mice) Dennis Farrelly, Karen S. Brown, Aaron Tieman, Jianming Ren, Sergio A. Lira, Deborah Hagan, Richard Gregg, Kasim A. Mookhtiar, and Narayanan Hariharan. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proceedings of the National Academy of Sciences, 96(25):14511–14516, December 1999. URL: http://dx.doi.org/10.1073/pnas.96.25.14511, doi:10.1073/pnas.96.25.14511. This article has 119 citations.](https://doi.org/10.1073/pnas.96.25.14511)

[6. (Rees2011Cellular) M. G. Rees, S. Wincovitch, J. Schultz, R. Waterstradt, N. L. Beer, S. Baltrusch, F. S. Collins, and A. L. Gloyn. Cellular characterisation of the gckr p446l variant associated with type 2 diabetes risk. Diabetologia, 55(1):114–122, October 2011. URL: http://dx.doi.org/10.1007/s00125-011-2348-5, doi:10.1007/s00125-011-2348-5. This article has 89 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-011-2348-5)

[7. (Simons2018Association) Pomme I. H. G. Simons, Nynke Simons, Coen D. A. Stehouwer, Casper G. Schalkwijk, Nicolaas C. Schaper, and Martijn C. G. J. Brouwers. Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: a systematic review and meta-analysis. PLOS ONE, 13(10):e0206174, October 2018. URL: http://dx.doi.org/10.1371/journal.pone.0206174, doi:10.1371/journal.pone.0206174. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0206174)

[8. (OrhoMelander2008Common) Marju Orho-Melander, Olle Melander, Candace Guiducci, Pablo Perez-Martinez, Dolores Corella, Charlotta Roos, Ryan Tewhey, Mark J. Rieder, Jennifer Hall, Goncalo Abecasis, E. Shyong Tai, Cullan Welch, Donna K. Arnett, Valeriya Lyssenko, Eero Lindholm, Richa Saxena, Paul I.W. de Bakker, Noel Burtt, Benjamin F. Voight, Joel N. Hirschhorn, Katherine L. Tucker, Thomas Hedner, Tiinamaija Tuomi, Bo Isomaa, Karl-Fredrik Eriksson, Marja-Riitta Taskinen, Björn Wahlstrand, Thomas E. Hughes, Laurence D. Parnell, Chao-Qiang Lai, Göran Berglund, Leena Peltonen, Erkki Vartiainen, Pekka Jousilahti, Aki S. Havulinna, Veikko Salomaa, Peter Nilsson, Leif Groop, David Altshuler, Jose M. Ordovas, and Sekar Kathiresan. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and c-reactive protein but lower fasting glucose concentrations. Diabetes, 57(11):3112–3121, November 2008. URL: http://dx.doi.org/10.2337/db08-0516, doi:10.2337/db08-0516. This article has 240 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/db08-0516)

[9. (Beck2013Structural) Tobias Beck and Brian G. Miller. Structural basis for regulation of human glucokinase by glucokinase regulatory protein. Biochemistry, 52(36):6232–6239, August 2013. URL: http://dx.doi.org/10.1021/bi400838t, doi:10.1021/bi400838t. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi400838t)

[10. (Zelent2014Analysis) Bogumil Zelent, Anne Raimondo, Amy Barrett, Carol W. Buettger, Pan Chen, Anna L. Gloyn, and Franz M. Matschinsky. Analysis of the co-operative interaction between the allosterically regulated proteins gk and gkrp using tryptophan fluorescence. Biochemical Journal, 459(3):551–564, April 2014. URL: http://dx.doi.org/10.1042/bj20131363, doi:10.1042/bj20131363. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20131363)

[11. (Yeh2022Pleiotropic) Kuan-Hung Yeh, Lung-An Hsu, Ming-Sheng Teng, Semon Wu, Hsin-Hua Chou, and Yu-Lin Ko. Pleiotropic effects of common and rare gckr exonic mutations on cardiometabolic traits. Genes, 13(3):491, March 2022. URL: http://dx.doi.org/10.3390/genes13030491, doi:10.3390/genes13030491. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13030491)

[12. (Shi2000Adaptor) Chong-Shan Shi, Joseph Tuscano, and John H. Kehrl. Adaptor proteins crk and crkl associate with the serine/threonine protein kinase gckr promoting gckr and sapk activation. Blood, 95(3):776–782, February 2000. URL: http://dx.doi.org/10.1182/blood.v95.3.776.003k23_776_782, doi:10.1182/blood.v95.3.776.003k23_776_782. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.v95.3.776.003k23_776_782)

[13. (Irwin2014Evolution) David M. Irwin and Huanran Tan. Evolution of glucose utilization: glucokinase and glucokinase regulator protein. Molecular Phylogenetics and Evolution, 70:195–203, January 2014. URL: http://dx.doi.org/10.1016/j.ympev.2013.09.016, doi:10.1016/j.ympev.2013.09.016. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.ympev.2013.09.016)

[14. (Massa2011Liver) María L. Massa, Juan J. Gagliardino, and Flavio Francini. Liver glucokinase: an overview on the regulatorymechanisms of its activity. IUBMB Life, 63(1):1–6, January 2011. URL: http://dx.doi.org/10.1002/iub.411, doi:10.1002/iub.411. This article has 162 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/iub.411)

[15. (Brouwers2015Modulation) Martijn C.G.J. Brouwers, Chantal Jacobs, Aalt Bast, Coen D.A. Stehouwer, and Nicolaas C. Schaper. Modulation of glucokinase regulatory protein: a double-edged sword? Trends in Molecular Medicine, 21(10):583–594, October 2015. URL: http://dx.doi.org/10.1016/j.molmed.2015.08.004, doi:10.1016/j.molmed.2015.08.004. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmed.2015.08.004)